Raleigh’s Salix acquires specialty drug company By: Business Journals November 07, 2013 at 17:20 PM EST Salix Pharmaceuticals announced it will acquire Santarus, Inc. for $32 per share. That price values Santarus (Nasdaq: SNTS) at $2... Read More >>